Results 241 to 250 of about 25,164 (313)

Effect of SSRIs on clinical progression in amnestic mild cognitive impairment stratified by Alzheimer's disease pathology. [PDF]

Alzheimers Dement
Li Y, Liu W, Wang X, Qin W, Liu Z, Lyu D, Li Y, Li B, Xu L, Cao S, Alzheimer's Disease Neuroimaging Initiative, Chong JRF, Lai MKP, Chen CLH, Jia J.   +14 more
europepmc   +1 more source

Progress in exercise interventions for autism spectrum disorder: exploring underlying mechanisms. [PDF]

Front Psychiatry
Wang C, Zhang Y, Zhu J, Lin Z.
europepmc   +1 more source

Targeting clathrin-mediated endocytosis: recent advances in inhibitor development, mechanistic insights, and therapeutic prospects. [PDF]

RSC Med Chem
Zhang C, Guo J, Liu Z, Huang X, Dong S, Hu C, Xiao J.   +6 more
europepmc   +1 more source

Exploring Consequences of Predator Stress on Behaviors of Mice Lacking Trace Amine-Associated Receptor 5 (TAAR5). [PDF]

Cells
Nemets VV, Grinevich VP, Petrunina EN, Budygin EA, Gainetdinov RR.   +4 more
europepmc   +1 more source

Navigating Solute Carrier Transporters-A Comprehensive Review of Functionalized Small Molecule Probes for Target Identification and Characterization. [PDF]

Med Res Rev
Dilweg MA, Widjaja T, IJzerman AP, van der Es D.   +3 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Fluoxetine, a selective serotonin uptake inhibitor

Clinical Pharmacology & Therapeutics, 1978
Fluoxetine is a selective serotonin uptake inhibitor in man. Platelets harvested from subjects to whom fluoxetine was administered (30 mg daily for 1 wk) had a diminished ability to accumulate 3H‐serotonin. The inhibition of uptake was positively correlated with the plasma concentrations of fluoxetine.
L, Lemberger, H, Rowe, R, Carmichael, R, Crabtree, J S, Horng, F, Bymaster, D, Wong   +6 more
openaire   +2 more sources

Inhibitors of Serotonin Uptake

1993
Over the past fifteen years selective serotonin uptake inhibitors such as fluoxetine, sertraline, citalopram, paroxetine, and litoxetine have been developed, some of which are currently widely used in the clinical management of affective disorders. These selective uptake inhibitors have provided powerful probes to undertake molecular pharmacological ...
S Z Langer, D Graham
openaire   +1 more source